Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis

Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis

Abstract Background Not all breast cancer (BC) patients can benefit from neoadjuvant therapy (NAT). A poor response may result in patients missing the best opportunity for treatment, ultimately leading to a poor prognosis. Thus, to identify an effective predictor that can assess and predict patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuyi Niu, Tie Sun, Mozhi Wang, Litong Yao, Tianyi He, Yusong Wang, Hengjun Zhang, Xiang Li, Yingying Xu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Circulating tumor DNA
Breast cancer
Neoadjuvant therapy
Prognosis
Response
Biomarkers
Online Access:https://doi.org/10.1186/s12885-025-13526-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-13526-0

Similar Items